24/7 Patient Assistance: 760-405-8205

Rodrigo Cartin-Ceba, MD

Pulmonologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Lung Cancer Pleural Effusions

specialties & services

  • Bio & Insurance Information

    Dr. Rodrigo Cartin-Ceba graduated the medical school from the Universidad de Costa Rica Faculty of Medicine and completed his residency program at the Baylor College of Medicine. Two fellowships followed at the Mayo School of Graduate Medical Education soon after that. He is specialized in pulmonology and board certified in internal medicine, pulmonary disease, and critical care medicine. Dr. Ceba has been in practice for more than 11 years and is affiliated with the Mayo Clinic. During his career, he has also run a clinical trial and has published several writings of medical interest in collaboration with other doctors.


  • Education & Training

    dept_icon

    Universidad de Costa Rica Faculty of Medicine

    Medical School

    dept_icon

    Baylor College of Medicine

    Residency

    dept_icon

    Mayo School of Graduate Medical Education

    Fellowship

    dept_icon

    Mayo School of Graduate Medical Education

    Fellowship

  • Board Certifications

    American Board of Internal Medicine

    American Board of Internal Medicine - Critical Care Medicine

    American Board of Internal Medicine - Pulmonary Disease

  • Hospital & Practice

    Mayo Clinic Phoenix

    Languages: English/Spanish

    480-515-6296

    5777 East Mayo Boulevard

    Phoenix, Arizona 85054

    Read More

    Mayo Clinic Rochester

    Languages: English/Spanish

    507-284-2511

    200 S. W. First Street

    Rochester, Minnesota 55905

    Read More
  • Publications & Memberships

    Dr. Rodrigo Cartin-Ceba has contributed to 4 publications.

    A retrospective comparison of helicopter transport versus ground transport in patients with severe sepsis and septic shock.

    Kashyap R, Anderson PW, Vakil A, Russi CS, Cartin-Ceba R Int J Emerg Med 2016 Dec; 9 (1):15 Epub 2016 June 07

    See more >>

    The pharmacogenomic association of Fcgamma receptors and cytochrome p450 enzymes and response to treatment with rituximab or cyclophosphamide in Anti-Neutrophil Cytoplasmic Antibody-Associated vasculitis.

    RAVE-ITN Research Group, Cartin-Ceba R, Indrakanti D, Specks U, Stone JH, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Spiera RF, Monach PA, St Clair W, Seo P, Tchao NK, Ytterberg SR, Brunetta PG, Song H, Birmingham D, Rovin BH Arthritis Rheumatol 2016 Aug 2 Epub 2016 Aug 02

    See more >>

    Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3

    Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group, Fussner LA, Hummel AM, Schroeder DR, Silva F, Cartin-Ceba R, Snyder MR, Hoffman GS, Kallenberg CG, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, William St Clair E, Tchao NK, Stone JH, Specks U Arthritis Rheumatol 2016 Jul; 68 (7):1700-10

    See more >>

    Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes.

    Cartin-Ceba R, Diaz-Caballero L, Al-Qadi MO, Alqadi MO, Tryfon S, Fervenza FC, Ytterberg SR, Specks U Arthritis Rheumatol 2016 Jun; 68 (6):1467-76

    See more >>